Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.87 CAD | +1.21% | -0.51% | +1.91% |
Mar. 11 | National Bank Revises 2024, 2025 Estimates for Dexterra Group Following Q4 Results | MT |
Mar. 11 | Dexterra Upgraded to Outperform at Raymond James | MT |
Sales 2024 * | 1.16B 852M | Sales 2025 * | 1.16B 850M | Capitalization | 372M 272M |
---|---|---|---|---|---|
Net income 2024 * | 33M 24.16M | Net income 2025 * | 41M 30.02M | EV / Sales 2024 * | 0.4 x |
Net Debt 2024 * | 93.73M 68.63M | Net Debt 2025 * | 57.53M 42.13M | EV / Sales 2025 * | 0.37 x |
P/E ratio 2024 * |
11
x | P/E ratio 2025 * |
9.3
x | Employees | - |
Yield 2024 * |
6.03% | Yield 2025 * |
6.03% | Free-Float | 48.69% |
Latest transcript on Dexterra Group Inc.
1 day | -0.51% | ||
1 week | -1.02% | ||
Current month | +4.50% | ||
1 month | +2.65% | ||
3 months | -3.33% | ||
6 months | +4.13% | ||
Current year | +0.69% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Becker
CEO | Chief Executive Officer | - | 18-08-21 |
Denise Achonu
DFI | Director of Finance/CFO | - | Dec. 31 |
Christos Gazeas
LAW | General Counsel | - | 20-12-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Johnston
BRD | Director/Board Member | 83 | 20-05-28 |
Russell Newmark
BRD | Director/Board Member | 67 | 06-05-31 |
Kevin Nabholz
BRD | Director/Board Member | 67 | 12-05-02 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 5.87 | +1.21% | 6 805 |
24-04-25 | 5.8 | -0.51% | 7,257 |
24-04-24 | 5.83 | -2.35% | 39,071 |
24-04-23 | 5.97 | +1.19% | 4,660 |
24-04-22 | 5.9 | 0.00% | 52,499 |
Delayed Quote Toronto S.E., April 25, 2024 at 03:39 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.69% | 272M | |
+7.29% | 69.74B | |
+11.99% | 50.99B | |
+13.23% | 16.24B | |
+15.99% | 15.3B | |
+21.82% | 11.05B | |
+29.70% | 9.86B | |
+12.71% | 5.09B | |
+10.53% | 4.65B | |
+22.47% | 3.77B |
- Stock Market
- Equities
- DXT Stock